Ligand Pharmaceuticals (LGND) Cash & Equivalents (2010 - 2026)
Ligand Pharmaceuticals (LGND) recorded Cash & Equivalents of $1.01 billion in Q2 2026, compared with $67.67 million a year earlier and up 774.8% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Ligand Pharmaceuticals reported Cash & Equivalents of $174.93 million, up 141.9% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 29.7% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $72.31 million in FY2024 (+215.0%), $22.95 million in FY2023 (-49.0%), $45.01 million in FY2022 (+130.5%) and $19.52 million in FY2021 (-59.0%).
- The Q2 2026 figure is the highest quarterly Cash & Equivalents in data going back to Q2 2010.
- On a year-over-year basis, Cash & Equivalents rose in six of the last seven quarters, with growth averaging 159.2%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 491.8% in Q1 2023, against a decline of 94.9% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $115.08 million (Q1 2026), $174.93 million (Q4 2025) and $139.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Ligand Pharmaceuticals | 6.03 Bn | 2.50 Bn | - | 1.01 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 115.08 Mn |
| Dec 31, 2025 | 174.93 Mn |
| Sep 30, 2025 | 139.38 Mn |
| Jun 30, 2025 | 67.67 Mn |
| Mar 31, 2025 | 47.99 Mn |
| Dec 31, 2024 | 72.31 Mn |
| Sep 30, 2024 | 63.62 Mn |
| Jun 30, 2024 | 18.14 Mn |
| Mar 31, 2024 | 50.09 Mn |
| Dec 31, 2023 | 22.95 Mn |
| Sep 30, 2023 | 19.28 Mn |
| Jun 30, 2023 | 28.45 Mn |
| Mar 31, 2023 | 88.73 Mn |
| Dec 31, 2022 | 45.01 Mn |
| Sep 30, 2022 | 4.12 Mn |
| Jun 30, 2022 | 5.28 Mn |
| Mar 31, 2022 | 14.99 Mn |
| Dec 31, 2021 | 19.52 Mn |
| Sep 30, 2021 | 23.43 Mn |
API Access
Ligand Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();